Engineered for controlled release, adhesive coatings enable precise medication delivery through the skin or mucosal surfaces in a patient-friendly, non-invasive format. Each formulation has tunable properties, such as multilayer designs, polymer composition, and pH sensitivity, ensuring reliable performance for existing and novel APIs.
60+ years of adhesives expertise
FDA-Approved, GRAS-Compliant Materials
Scalable Production with Tight Content Uniformity Controls
Adhesive coatings deliver APIs through a specialized polymer matrix, allowing controlled or extended release. Their composition can be tailored to specific therapeutic needs, providing a versatile, skin-friendly solution that enhances patient comfort and adherence.
Buccal films adhere to the cheek, providing controlled release for sustained dosing and enhanced bioavailability.
Topical patches deliver medication directly to specific skin areas, providing localized treatment with minimal systemic absorption.
Transdermal patches deliver medication through the skin into the bloodstream, providing steady, controlled drug release over extended periods.
Adhesive coatings offer a convenient, discreet delivery method.
With over 60 years of experience, ARx delivers flexible, patient-friendly adhesive solutions using FDA-approved materials.
From feasibility studies to production, our team ensures a reliable, high-quality end product.
Curious how adhesive coatings compare to traditional drug delivery systems?
Discover their unique benefits, including customizable release profiles, enhanced bioavailability, and superior patient compliance.
Have questions about how adhesive coatings can enhance your therapeutic area? Connect with ARx to see how decades of adhesive development and drug delivery expertise can help develop your ideal end product.
